New York Eye and Ear Infirmary
Adjust: Text Size Make Font Smaller Make Font Larger Print this Page: Normal Print Friendly Large Print Friendly Accessibility Info

Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON)

This study is currently recruiting participants.

A 48- week, double blind, randomized, multi-center, parallel group study comparing structural changes in the retina and evolution of visual function after immediate versus delayed treatment with fingolimod in patients with acute demyelinating optic neuritis

Inclusion Criteria:

  • Ages 18 Years to 50 Years
  • Clinical signs and symptoms of ADON in one eye (loss of vision, pain on movement, impairment of color vision)
  • First episode of ADON
  • Able to undergo treatment with IV steroids

Contact Information

Dr. Rudrani Banik, Neuro-Ophthalmologist

Melissa Rivas, Research Coordinator at 212-614-8386

 

Home > Current Research > Clinical Trials in Ophthalmology >Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON)